Skip to main content
. 2019 Oct 31;59(5):641–648. doi: 10.2169/internalmedicine.3646-19

Table 2.

Cases of Liver Sarcoidosis in Our Hospital

Case Age
(years)
Sex Affected organs Splenomegaly Treatment Efficacy of treatment
1 39 M Neuron, Lymph nodes Mild PSL No change
2 23 M Eye Moderate -
3 74 F Skin Mild -
4 69 M Neuron - PSL No change
5 40 M Eye - (PSL)* No change
6 41 M Lymph nodes Marked -
7 44 F Eye Mild UDCA Decreased liver enzymes
8 49 F Heart, eye -
9 71 F Eye -
10 44 M Lung, eye Mild UDCA No change
11 70 F UDCA Exacerbation
12 52 M Heart, Lung PSL Exacerbation
13 41 M Eye, skin Marked PSL, UDCA Exacerbation
14
(Present case)
22 F Lung, skin, spleen Marked Splenectomy Favorable

*PSL was administered to treat facial nerve palsy. PSL: prednisone, UDCA: ursodeoxycholic acid